The Discounted Cash Flow (DCF) valuation of ANI Pharmaceuticals Inc (ANIP) is 108.51 USD. With the latest stock price at 74.21 USD, the upside of ANI Pharmaceuticals Inc based on DCF is 46.2%.
Based on the latest price of 74.21 USD and our DCF valuation, ANI Pharmaceuticals Inc (ANIP) is a buy. buying ANIP stocks now will result in a potential gain of 46.2%.
| Range | Selected | |
| WACC / Discount Rate | 6.0% - 8.1% | 7.0% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | 74.01 - 190.82 | 108.51 |
| Upside | -0.3% - 157.1% | 46.2% |